Liver Cancer

6 products · Page 1 of 1

All small molecule research tools

DC5032

AZD1480

AZD1480 is a novel ATP-competitive JAK2 inhibitor with IC50 of 0.26 nM, selectivity against JAK3 and Tyk2, and to a smaller extent against JAK1. IC50 value: 0.26 nM Target: JAK2 in vitro: AZD1480 demonstrated…

View activity & prices

DC10092

BLU554(Fisogatinib)

BLU-554 is a potent fibroblast growth factor receptor 4 (FGFR4) inhibitor.

View activity & prices

DC10128

FGF401( Roblitinib)

FGF-401 is an inhibitor of FGFR4 extracted from patent WO2015059668A1, compound example 83; has an IC50 of 1.9 nM.

View activity & prices

DC10033

H3B-6527

H3B-6527 (H3 Biomedicine) is a highly selective FGFR4 inhibitor with potent antitumour activity in FGF19 amplified cell lines and mice.

View activity & prices

DC7065

Tivantinib (ARQ 197)

Tivantinib is a novel and highly selective c-Met tyrosine kinase inhibitor with Ki of 355 nM.

View activity & prices

DC10440

Namodenoson (CF-102)

Namodenoson (CF-102) is a selective A3 adenosine receptor agonist (Ki = 0.33 nM). Displays 2500- and 1400-fold selectivity over A1 and A2A receptors respectively.

View activity & prices